A new £2.1 million project, GLUTRONICS, aims to revolutionize implantable medical devices by harnessing power from glucose in the body.
The project, led by the University of Bath in collaboration with the Universities of Newcastle, Oxford, and Sheffield, will develop glucose-powered bioelectronics to help patients with life-long conditions such as neurodegenerative diseases, diabetes, and heart conditions.
The technology, short for Glucose-fuelled ultra-low power implantable bioelectronics, addresses the invasiveness and limitations of current implantable devices by eliminating the need for bulky battery packs.
The GLUTRONICS project will develop a new generation of implantable medical devices powered by natural sugars in the body.
Author's summary: GLUTRONICS project to transform implantable medical devices with glucose-powered technology.